John B. Sanfilippo & Son, Inc. (JBSS) Insider Trading
Insiders sold $1.45M and bought nothing on the open market.
All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Dec 2023.
Get an email when JBSS's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2 | James J Sanfilippo Director | Sold10b5-1 plan | 1,268 | $80.63 | $102k | 45% | Form 4 |
| Mar 2 | Jeffrey T Sanfilippo Chief Executive Officer | Sold10b5-1 plan | 7,212 | $80.08 | $578k | 15% | Form 4 |
| Mar 2 | Jasper Brian Sanfilippo Jr COO, President | Sold10b5-1 plan | 7,212 | $80.97 | $584k | 20% | Form 4 |
| Mar 2 | Lisa Sanfilippo Director | Sold10b5-1 plan | 2,272 | $81.43 | $185k | 60% | Form 4 |
| Feb 11, 2025 | James J Sanfilippo Director | Sold10b5-1 plan | 1,004 | $70.67 | $71k | 44% | Form 4 |
| Jan 16, 2025 | Jeffrey T Sanfilippo Chief Executive Officer | Sold10b5-1 plan | 5,158 | $90.00 | $464k | 17% | Form 4 |
| Jan 16, 2025 | Jasper Brian Sanfilippo Jr COO, President | Sold10b5-1 plan | 5,158 | $90.00 | $464k | 17% | Form 4 |
- Mar 210b5-1 planJames J SanfilippoDirector · sold 1,268 at $80.63$102k45% of stake
- Mar 210b5-1 planJeffrey T SanfilippoChief Executive Officer · sold 7,212 at $80.08$578k15% of stake
- Mar 210b5-1 planJasper Brian Sanfilippo JrCOO, President · sold 7,212 at $80.97$584k20% of stake
- Mar 210b5-1 planLisa SanfilippoDirector · sold 2,272 at $81.43$185k60% of stake
- Feb 11, 202510b5-1 planJames J SanfilippoDirector · sold 1,004 at $70.67$71k44% of stake
- Jan 16, 202510b5-1 planJeffrey T SanfilippoChief Executive Officer · sold 5,158 at $90.00$464k17% of stake
- Jan 16, 202510b5-1 planJasper Brian Sanfilippo JrCOO, President · sold 5,158 at $90.00$464k17% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Sugar & Confectionery Products
Spot a number that looks wrong? Check it in JBSS's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing JBSS
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.